Gufic Stridden Bio-Pharma Private Limited, a amalgamated private limited company, was established on 27 January 2007 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24110MH2007PTC167101. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.
Its leadership includes Dilip Ghosh (Whole-Time Director), Jayesh Pannalal Choksi (Director), Dipanjan Dilip Ghosh (Director). Past directors included Dilip Ghosh, Dipanjan Dilip Ghosh. Its latest AGM occurred on 29 September 2017, with the balance sheet filed on 31 March 2017. It is based at 37, First Floor, Kamla Bhavan Ii, S Nityanand Road, Andheri East, Mumbai, Maharashtra, 400069.
U24110MH2007PTC167101
167101
27 January 2007
₹0.20 M
₹0.20 M
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Gufic Stridden Bio-Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilip Ghosh | Whole-Time Director | 27 Jan 2007 | Current |
| Jayesh Pannalal Choksi | Director | 27 Jan 2007 | Current |
| Dipanjan Dilip Ghosh | Director | 01 Feb 2012 | Current |
| Pranav Jayesh Choksi | Director | 27 Jan 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2010 | Past |
| Pramod Abcsdd | Director | 01 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gufic Stridden Bio-Pharma Private Limited, for the financial year ended 2014, experienced significant growth in revenue, with a 163.59% increase. The company also saw a substantial improvement in profitability, with a 485.49% increase in profit. The company's net worth Soared by an impressive increase of 133.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Gufic Stridden Bio-Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gufic Stridden Bio-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gufic Stridden Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gufic Stridden Bio-Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gufic Stridden Bio-Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records. was documented.
Gufic Stridden Bio-Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was recorded as a recent event.
The activity Dipanjan Dilip Ghosh was appointed as a Director was appointed as a Director on 01 Feb 2012 & has been associated with this company since 13 years 9 months . was completed.
Dilip Ghosh was appointed as a Whole-time director was appointed as a Whole-time director on 27 Jan 2007 & has been associated with this company since 18 years 10 months . was recorded as a recent event.
Jayesh Pannalal Choksi was appointed as a Director was appointed as a Director on 27 Jan 2007 & has been associated with this company since 18 years 10 months . was recorded as a recent event.
Pranav Jayesh Choksi was appointed as a Director was appointed as a Director on 27 Jan 2007 & has been associated with this company since 18 years 10 months . was recorded as a recent event.
The CIN of Gufic Stridden Bio-Pharma Private Limited is U24110MH2007PTC167101.
Gufic Stridden Bio-Pharma Private Limited is headquartered at 37, First Floor, Kamla Bhavan Ii, S Nityanand Road, Andheri East, Mumbai, Maharashtra, 400069.
Gufic Stridden Bio-Pharma Private Limited was incorporated on 27 January 2007.
The current directors of Gufic Stridden Bio-Pharma Private Limited are
The primary industry of Gufic Stridden Bio-Pharma Private Limited is Manufacturing.
Gufic Stridden Bio-Pharma Private Limited is unlisted.
The authorized capital of Gufic Stridden Bio-Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX